Effects of CDK8/19 Mediator Kinase inhibition on gene expression in castration-resistant prostate cancer cell line 22Rv1 and its derivatives grown in vitro.
RNA-seq (gene expression) · human · 48 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 48 samples: 16 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Mediator kinase inhibition reverses castration resistance of advanced prostate cancerThe Journal of clinical investigation · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE240369_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1003453 and SRA study SRP454049. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 48 samples.
How we read this: 16 replicated groups read from 48 sample titles; they account for 48 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7696909 Rv1_WT_FBS_Ctrl_3d_Rep1 Rv1_WT_FBS_Ctrl_3d
- GSM7696910 Rv1_WT_FBS_Ctrl_3d_Rep2 Rv1_WT_FBS_Ctrl_3d
- GSM7696911 Rv1_WT_FBS_Ctrl_3d_Rep3 Rv1_WT_FBS_Ctrl_3d
- GSM7696912 Rv1_WT_FBS_SNX631_3d_Rep1 Rv1_WT_FBS_SNX631_3d
- GSM7696913 Rv1_WT_FBS_SNX631_3d_Rep2 Rv1_WT_FBS_SNX631_3d
- GSM7696914 Rv1_WT_FBS_SNX631_3d_Rep3 Rv1_WT_FBS_SNX631_3d
- GSM7696915 Rv1_WT_CSS_Ctrl_3d_Rep1 Rv1_WT_CSS_Ctrl_3d
- GSM7696916 Rv1_WT_CSS_Ctrl_3d_Rep2 Rv1_WT_CSS_Ctrl_3d
- GSM7696917 Rv1_WT_CSS_Ctrl_3d_Rep3 Rv1_WT_CSS_Ctrl_3d
- GSM7696918 Rv1_WT_CSS_SNX631_3d_Rep1 Rv1_WT_CSS_SNX631_3d
- GSM7696919 Rv1_WT_CSS_SNX631_3d_Rep2 Rv1_WT_CSS_SNX631_3d
- GSM7696920 Rv1_WT_CSS_SNX631_3d_Rep3 Rv1_WT_CSS_SNX631_3d
- GSM7696921 Rv1_Luc_FBS_Ctrl_3d_Rep1 Rv1_Luc_FBS_Ctrl_3d
- GSM7696922 Rv1_Luc_FBS_Ctrl_3d_Rep2 Rv1_Luc_FBS_Ctrl_3d
- GSM7696923 Rv1_Luc_FBS_Ctrl_3d_Rep3 Rv1_Luc_FBS_Ctrl_3d
- GSM7696924 Rv1_Luc_FBS_SNX631_3d_Rep1 Rv1_Luc_FBS_SNX631_3d
- GSM7696925 Rv1_Luc_FBS_SNX631_3d_Rep2 Rv1_Luc_FBS_SNX631_3d
- GSM7696926 Rv1_Luc_FBS_SNX631_3d_Rep3 Rv1_Luc_FBS_SNX631_3d
- GSM7696927 Rv1_Luc_CSS_Ctrl_3d_Rep1 Rv1_Luc_CSS_Ctrl_3d
- GSM7696928 Rv1_Luc_CSS_Ctrl_3d_Rep2 Rv1_Luc_CSS_Ctrl_3d
- GSM7696929 Rv1_Luc_CSS_Ctrl_3d_Rep3 Rv1_Luc_CSS_Ctrl_3d
- GSM7696930 Rv1_Luc_CSS_SNX631_3d_Rep1 Rv1_Luc_CSS_SNX631_3d
- GSM7696931 Rv1_Luc_CSS_SNX631_3d_Rep2 Rv1_Luc_CSS_SNX631_3d
- GSM7696932 Rv1_Luc_CSS_SNX631_3d_Rep3 Rv1_Luc_CSS_SNX631_3d
- GSM7696933 Rv1_DKO_CDK8_FBS_Ctrl_3d_Rep1 Rv1_DKO_CDK8_FBS_Ctrl_3d
- GSM7696934 Rv1_DKO_CDK8_FBS_Ctrl_3d_Rep2 Rv1_DKO_CDK8_FBS_Ctrl_3d
- GSM7696935 Rv1_DKO_CDK8_FBS_Ctrl_3d_Rep3 Rv1_DKO_CDK8_FBS_Ctrl_3d
- GSM7696936 Rv1_DKO_CDK8_FBS_SNX631_3d_Rep1 Rv1_DKO_CDK8_FBS_SNX631…
- GSM7696937 Rv1_DKO_CDK8_FBS_SNX631_3d_Rep2 Rv1_DKO_CDK8_FBS_SNX631…
- GSM7696938 Rv1_DKO_CDK8_FBS_SNX631_3d_Rep3 Rv1_DKO_CDK8_FBS_SNX631…
- GSM7696939 Rv1_DKO_CDK8M_FBS_Ctrl_3d_Rep1 Rv1_DKO_CDK8M_FBS_Ctrl_…
- GSM7696940 Rv1_DKO_CDK8M_FBS_Ctrl_3d_Rep2 Rv1_DKO_CDK8M_FBS_Ctrl_…
- GSM7696941 Rv1_DKO_CDK8M_FBS_Ctrl_3d_Rep3 Rv1_DKO_CDK8M_FBS_Ctrl_…
- GSM7696942 Rv1_DKO_CDK8M_FBS_SNX631_3d_Rep1 Rv1_DKO_CDK8M_FBS_SNX63…
- GSM7696943 Rv1_DKO_CDK8M_FBS_SNX631_3d_Rep2 Rv1_DKO_CDK8M_FBS_SNX63…
- GSM7696944 Rv1_DKO_CDK8M_FBS_SNX631_3d_Rep3 Rv1_DKO_CDK8M_FBS_SNX63…
- GSM7696945 Rv1_DKO_CDK19_FBS_Ctrl_3d_Rep1 Rv1_DKO_CDK19_FBS_Ctrl_…
- GSM7696946 Rv1_DKO_CDK19_FBS_Ctrl_3d_Rep2 Rv1_DKO_CDK19_FBS_Ctrl_…
- GSM7696947 Rv1_DKO_CDK19_FBS_Ctrl_3d_Rep3 Rv1_DKO_CDK19_FBS_Ctrl_…
- GSM7696948 Rv1_DKO_CDK19_FBS_SNX631_3d_Rep1 Rv1_DKO_CDK19_FBS_SNX63…
+ 8 more — browse all 48 samples with per-sample file links →
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing · shares 22rv1, prostate
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing · shares prostate
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing · shares prostate
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing · shares prostate
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE240167 Effects of CDK8/19 Mediator Kinase inhibition by Senexin B and SNX631 on androgen-regulated gene expression in LNCaP cells 28 samples shares cdk8, inhibition, mediator, kinase
- GSE275778 AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer [RNA-seq: 22RV1] 20 samples shares 22rv1, mediator, prostate
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.